- Home
- HLXB vs RCEL Comparison
HLXB vs RCEL Comparison
Compare HLXB & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLXB
- RCEL
- Stock Information
- Founded
- HLXB 2021
- RCEL 2020
- Country
- HLXB United States
- RCEL United States
- Employees
- HLXB N/A
- RCEL N/A
- Industry
- HLXB
- RCEL Medical/Dental Instruments
- Sector
- HLXB
- RCEL Health Care
- Exchange
- HLXB NYSE
- RCEL Nasdaq
- Market Cap
- HLXB 243.6M
- RCEL 274.7M
- IPO Year
- HLXB 2024
- RCEL N/A
- Fundamental
- Price
- HLXB $10.47
- RCEL $11.73
- Analyst Decision
- HLXB
- RCEL Hold
- Analyst Count
- HLXB 0
- RCEL 3
- Target Price
- HLXB N/A
- RCEL $15.00
- AVG Volume (30 Days)
- HLXB 9.2K
- RCEL 72.1K
- Earning Date
- HLXB 01-01-0001
- RCEL 11-07-2024
- Dividend Yield
- HLXB N/A
- RCEL N/A
- EPS Growth
- HLXB N/A
- RCEL N/A
- EPS
- HLXB N/A
- RCEL N/A
- Revenue
- HLXB N/A
- RCEL $54,139,000.00
- Revenue This Year
- HLXB N/A
- RCEL $40.31
- Revenue Next Year
- HLXB N/A
- RCEL $45.42
- P/E Ratio
- HLXB N/A
- RCEL N/A
- Revenue Growth
- HLXB N/A
- RCEL 32.53
- 52 Week Low
- HLXB $10.03
- RCEL $7.51
- 52 Week High
- HLXB $10.83
- RCEL $18.93
- Technical
- Relative Strength Index (RSI)
- HLXB N/A
- RCEL 73.51
- Support Level
- HLXB N/A
- RCEL $10.05
- Resistance Level
- HLXB N/A
- RCEL $11.55
- Average True Range (ATR)
- HLXB 0.00
- RCEL 0.55
- MACD
- HLXB 0.00
- RCEL 0.20
- Stochastic Oscillator
- HLXB 0.00
- RCEL 91.15
About HLXB HELIX ACQUISITION CORP. II
Helix Acquisition Corp II is a Blank check company.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.